DR. REDDY'S BIO-SCIENCES LIMITED
Location
Telangana
Founded
2000-06-27
Website
Risk Signals
1 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations, In Vitro and In Vivo Diagnostic Substances), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about DR. REDDY'S BIO-SCIENCES LIMITED
Live alerts from global media, monitored by Business Radar
2025-02-06 (stocktitan.net)
Henlius and Dr. Reddy's Ink Licensing Deal for HLX15 (investigational daratumumab biosimilar) Expansion in Europe and the U.S.
Henlius partners with Dr. Reddy's, receiving $33M upfront plus $131.6M in potential milestones for HLX15 daratumumab biosimilar rights across US and European markets.
Read more